Jakarta, CNBC Indonesia – Shares of pharmaceutical issuers on the Indonesia Stock Exchange (IDX) are ‘rivaled’ in the midst of the Covid-19 pandemic, which still makes the Composite Stock Price Index (JCI) move unstable even though it is still at the level of 6,000.
During the early days of the Covid-19 pandemic, pharmaceutical stock prices rose insanely. Pharmaceutical BUMN which is a subsidiary of PT Bio Farma, namely PT Indofarma Tbk (INAF) and PT Kimia Farma Tbk (KAEF) had recorded an increase of more than 100% in the middle of last year.
However, some time later the price of pharmaceutical stocks had collapsed. Its existence is also increasingly ‘threatened’ by investors when the shares of technology issuers begin to climb up.
Most recently, the shares of PT DCI Indonesia Tbk (DCII) which is engaged in the data center business shot 14,000% in 6 months. This raises the question, are pharmaceutical stocks no longer sexy and lose to techno stocks?
“Both are interesting because long-term techno structures are needed and since the pandemic we have realized the lack of health care,” said Head of Research at PT Trimegah Sekuritas Indonesia Tbk (TRIM), Willinoy Sitorus in CNBC Indonesia’s Investime program, quoted Tuesday (13/7/21). ).
“So I think the government’s budget will focus health sector. Prodia shares, then from hospital Siloam, Bunda Hospital and so on will benefit,” he said.
The shares mentioned were PT Prodia Widyahusada Tbk (PRDA) which rose 149% year to date until last Tuesday at the level of Rp 8,100/share, then PT Siloam International Hospitals Tbk (SILO) rose 81% at Rp 9,975/share, and the manager of Bunda Hospital, PT Bundamedik tbk (BMHS).
BHMS shares were only listed on the IDX on Tuesday, July 6th and have shot up 5 days in a row (correction for one day on Tuesday, -4.39%) at the level of Rp 980/share, so that a week it shot up 131%.
He assessed, there is a difference in looking at stocks and sectors that have the potential to be hunted by investors.
According to him, looking at pharmaceutical stocks is more about the condition of each company being good cashflow or cash flow or the health of the company.
Meanwhile, to look at technology stocks, it is necessary to look at the long term for years to come, because it is related to the future. However, the condition of the company is also a concern.
“It’s different from the old economy, we’ll see historical cashflow, in detail. If you look at the tech economy, we’re talking about the future,” he said.
Related to stocks tech, DCII data center issuers are indeed a concern. Since being listed on the IDX on January 6, 2021, the share price has skyrocketed 14,000% to Rp 59,000/share from Rp 420/share at the general offering price (IPO).
Currently DCII shares are still suspended by the IDX since last June 17.
Shares of other data center issuers, a group with DCI, namely PT Indointernet Tbk (EDGE) have also skyrocketed. In trading session II, Tuesday (13/7), EDGE shares fell 6.50% at Rp 30,925/share. However, its shares have skyrocketed 319% from the IPO price of Rp 7,375 per share on February 8, 2021.
(bag bag)
– .
/i/2003289822.png?resize=150%2C150&ssl=1)